Results 41 to 50 of about 1,008 (88)

Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas. [PDF]

Endocr Relat Cancer
Hernandez-Felix JH, Golagha M, Jha A, Varghese D, Grozinsky-Glasberg S, Riechelmann R, Fazio N, Pavel M, Lin FI, Taïeb D, Pacak K, Del Rivero J.   +11 more
europepmc   +1 more source

Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers. [PDF]

J Neuroendocrinol
Deroose CM, Ambrosini V, Hofland J, Kaltsas G, Kjaer A, Lamarca A, Sowa-Staszczak A, Janson ET, Fazio N.   +8 more
europepmc   +1 more source

Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. [PDF]

Front Endocrinol (Lausanne)
Kolodziej M, Opalinska M, Mikolajczak R, Hubalewska-Dydejczyk A, Dedecjus M, Kowalska A, Saracyn M, Garnuszek P, Cieszykowska I, Januszkiewicz-Caulier J, Dlugosinska J, Durma AD, Jozwik-Plebanek K, Mroz A, Janiak K, Gasior-Perczak D, Trofimiuk-Muldner M, Sowa-Staszczak A, Braziewicz J, Lenda-Tracz W, Kacperski K, Budzynska A, Kubik A, Pastusiak P, Chalewska W, Borkowska A, Cegla P, Walecka-Mazur A, Szczodry A, Kaminski G.   +29 more
europepmc   +1 more source

Drug interactions involving therapeutic radiopharmaceuticals: a systematic review. [PDF]

EJNMMI Radiopharm Chem
Gacon R, Chapuis R, Fabris-Davet L, Ranjit N, Goutelle S, Bourguignon L, Flaus A, Bolot C, Levigoureux E, Gallet M, Chaib S.   +10 more
europepmc   +1 more source

Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3. [PDF]

Pharmaceuticals (Basel)
Greifenstein L, Martin M, Stephan S, Eismant A, Kramer CS, Landvogt C, Mueller C, Rösch F, Baum RP.   +8 more
europepmc   +1 more source

CD70-targeted platform for diagnosing and treating multiple myeloma. [PDF]

J Immunother Cancer
Li J, Yan H, Wang X, Zhang Y, Chen P, Feng J, Zhang R, Li Z, Huang Z, Xu C, Ma N, Lin X, Zhao M, Zhu W, Peng Q, Xie S, Wei W, Dong M.   +17 more
europepmc   +1 more source

PARP Inhibitors as Radiosensitizers: Current Evidence and Future Directions. [PDF]

Curr Oncol Rep
Pereira E, Pereira F, Campos G, Abrantes AM, Botelho MF, Silva-Vaz P, Pires AS.   +6 more
europepmc   +1 more source

Theranostic Approaches to Radioiodine-Refractory Differentiated Thyroid Cancer: A Narrative Review. [PDF]

Cancers (Basel)
Petranović Ovčariček P, Tuncel M, Huellner MW, Campennì A, Giovanella L.   +4 more
europepmc   +1 more source